Chimene Kesserwan
- Molecular Biology
- Genetics top 10%
- Oncology
- Hematology top 5%
- Cancer Research
- Co-authors
- Kim E. NicholsJessica M. ValdezFabio CandottiRobert SokolicGang WuBrent A. OrrEmília M. PintoMichael R. Clay
- Topics
- Virus-based gene therapy research (5 papers)Cancer Genomics and Diagnostics (5 papers)Cancer-related Molecular Pathways (5 papers)
- Cited by
- HematologyGenetics
- Partner nations
- United StatesCanadaAustralia
In The Last Decade
Chimene Kesserwan
24 papers receiving 658 citations
Peers
Comparison fields: 5 of 68
- Molecular Biology 240
- Genetics 224
- Oncology 179
- Hematology 153
- Cancer Research 118
Countries citing papers authored by Chimene Kesserwan
This map shows the geographic impact of Chimene Kesserwan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chimene Kesserwan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chimene Kesserwan more than expected).
Fields of papers citing papers by Chimene Kesserwan
This network shows the impact of papers produced by Chimene Kesserwan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chimene Kesserwan. The network helps show where Chimene Kesserwan may publish in the future.
Co-authorship network of co-authors of Chimene Kesserwan
This figure shows the co-authorship network connecting the top 25 collaborators of Chimene Kesserwan. A scholar is included among the top collaborators of Chimene Kesserwan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chimene Kesserwan. Chimene Kesserwan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 11 | |
| 2 | 80 | |
| 3 | 22 | |
| 4 | 20 | |
| 5 | 42 | |
| 6 | 4 | |
| 7 | 18 | |
| 8 | 3 | |
| 9 | 27 | |
| 10 | 130 | |
| 11 | 65 | |
| 12 | 31 | |
| 13 | 39 | |
| 14 | 3 | |
| 15 | 27 | |
| 16 | 3 | |
| 17 | 2 | |
| 18 | 1 | |
| 19 | 25 | |
| 20 | Neoadjuvant therapy with celecoxib to women with early stage breast cancer. | 6 |
About Chimene Kesserwan
Chimene Kesserwan is a scholar working on Oncology, Genetics and Cancer Research, having authored 24 papers that have together received 661 indexed citations. Recurring topics across this work include Virus-based gene therapy research (5 papers), Cancer Genomics and Diagnostics (5 papers) and Cancer-related Molecular Pathways (5 papers). The work is most often cited by research in Hematology (153 citations), Genetics (91 citations) and Genetics (224 citations). Chimene Kesserwan has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Kim E. Nichols, Jessica M. Valdez, Fabio Candotti, Robert Sokolic, Gang Wu, Brent A. Orr, Emília M. Pinto, Michael R. Clay, Lainie Friedman Ross and John Easton. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.